| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785988 | Clinical Oncology | 2018 | 8 Pages |
Abstract
Patients with recurrent HGG tolerated re-irradiation well with minimal toxicity. Those patients in good prognostic groups, including good performance status can achieve durable control, suggesting managing patients with regular magnetic resonance imaging surveillance post-radical treatment, identifying early radiological progression and instituting salvage therapy when performance status is best.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L. Klobukowski, A. Falkov, C. Chelimo, S.E. Fogh,